GERMANY - Interest grows in Altana Pharma from various quarters

According to a report in Financial Times Deutschland the pharmaceutical arm of Altana is a potential target for a range of high profile buyers. These could include EQT in collaboration with Hexal founders Thomas and Andreas Strüngmann and ex-Merck head Bernhard Scheuble; KKR; Belgian chemical and pharmaceutical company Solvay and Danish Nyomed, which is backed by Nordic Capital, Blackstone and Credit Suisse Private Equity.